AI assistant
METLIFE INC — Director's Dealing 2019
Feb 28, 2019
29995_dirs_2019-02-28_af613916-1db9-4d4b-9f12-f516eb46201d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: METLIFE INC (MET)
CIK: 0001099219
Period of Report: 2019-02-26
Reporting Person: Lee Esther (EVP & Chief Marketing Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-02-26 | Common Stock | A | 12776 | $44.65 | Acquired | 26513 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-02-26 | Employee Stock Option (Right to Buy) | $44.65 | A | 12097 | Acquired | 2029-02-25 | Common Stock (12097) | Direct |
| 2019-02-26 | Restricted Stock Units | $ | A | 4032 | Acquired | Common Stock (4032) | Direct |
Footnotes
F1: The Reporting Person acquired these deferred shares from the 2016-2018 Performance Shares pursuant to the MetLife, Inc. 2015 Stock and Incentive Compensation Plan and the MetLife Leadership Deferred Compensation Plan, under which Executive Officers may elect to defer receipt of such stock for a specific period of time.
F2: The options become exercisable in three installments on February 26, 2020, 2021 and 2022.
F3: Each Restricted Stock Unit is the contingent right to receive one share of MetLife, Inc. common stock.
F4: The Restricted Stock Units vest in three installments on March 2, 2020, March 1, 2021 and March 1, 2022.